The CEO of Google Mind has suggested clinical trials of the first drugs designed with the help of AI could begin this year.

Nobel Prize winner Demis Hassabis thinks human trials will happen soon Clinical trials of the first drugs designed with the ...

A Lloyd's of London company partnered with GATC Health to fund and insure prospective drug trials that pass the test of a new AI technology.

The discovery and development of drugs in pharmacological research – including the risk assessment of active substances in ...

A team of scientists at the University of Toronto have successfully implemented AI tools to speed up the process of ...

Google's DeepMind spinoff Isomorphic Labs expects clinical trials of drugs designed using AI to start late this year.

The successful and safe delivery of therapeutics relies on understanding how easily drugs can pass through biological barriers which protect cells.

Insilico Medicine (“Insilico”), a clinical stage generative artificial intelligence (AI)-driven biotechnology company has ...

The proof-of-concept demonstrates the power of pairing AI with lab orchestration solutions to automate molecular screening ...

AI is poised to revolutionize drug discovery, but uncertainty in developing protectable IP in this emerging field creates a host of potential ...